Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Chemmedchem|July 16, 2008
Structure-antioxidant activity relationships in a series of NO-donor phenolsPaolo Tosco, Elisabetta Marini, Barbara Rolando, et al.
Journal of Medicinal Chemistry|May 12, 2006
NO-donor phenols: a new class of products endowed with antioxidant and vasodilator propertiesDonatella Boschi, Gian Cesare Tron, Loretta Lazzarato, et al.
Bioorganic & Medicinal Chemistry|February 12, 2013
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agentsGabriele Montanaro, Massimo Bertinaria, Barbara Rolando, et al.
Biochemical Pharmacology|December 8, 2025
NLRP3 inhibition protects human coronary endothelial cells from oxidative and lipotoxic stressAstrid Parenti, Costanza Titi, Arianna Brovero, et al.
Pharmacological Research|December 2, 2015
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibitionMalvina Hoxha, Carola Buccellati, Valérie Capra, et al.
Journal of Medicinal Chemistry|December 25, 2010
Synthesis, physicochemical characterization, and biological activities of new carnosine derivatives stable in human serum as potential neuroprotective agentsMassimo Bertinaria, Barbara Rolando, Marta Giorgis, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2<i>H</i>-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 InhibitorSimone Gastaldi, Valentina Boscaro, Eleonora Gianquinto, et al.
European Journal of Medicinal Chemistry|March 15, 2011
Amodiaquine analogues containing NO-donor substructures: synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malariaMassimo Bertinaria, Stefano Guglielmo, Barbara Rolando, et al.
Vascular Pharmacology|March 17, 2025
Macrophage and cardiomyocyte roles in cardioprotection: Exploiting the NLRP3 Inflammasome inhibitor INF150Magalì Giordano, Saveria Femminò, Federica Blua, et al.
Frontiers in Pharmacology|December 19, 2018
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel InflammationCarolina Pellegrini, Matteo Fornai, Rocchina Colucci, et al.
Pageof 5